MediWound (MDWD) Cash from Operations (2013 - 2026)
MediWound (MDWD) posted quarterly Cash from Operations of 3016000.0 for Q4 2025, down 84.24% year-over-year from 19136403.1 in Q4 2024, and up 6.88% quarter-over-quarter from 3239000.0 in Q3 2025.
MediWound (MDWD) Cash from Operations (2013 - 2026) Analysis & Trends
MediWound's Cash from Operations history runs 13 years deep, the most recent figure standing at 3016000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 84.24% year-over-year to 3016000.0; the TTM figure through Dec 2025 stood at 16121000.0 (down 18.33% YoY), while the FY2025 annual figure was 16121000.0, down 18.33% from the prior year.
- Cash from Operations for Q4 2025 stood at 3016000.0, up from 3239000.0 in the prior quarter.
- The five-year high for Cash from Operations was 750000.0 in Q4 2022, with the low at 5756000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 3437000.0 (2023), against an average of 3172400.0.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 133.56% in 2022, then sank 806.75% in 2024.
- MediWound's Cash from Operations stood at 2235000.0 in 2021, then jumped by 133.56% to 750000.0 in 2022, then plunged by 448.67% to 2615000.0 in 2023, then jumped by 37.4% to 1637000.0 in 2024, then tumbled by 84.24% to 3016000.0 in 2025.
- Business Quant data shows MDWD's Cash from Operations at 3016000.0 in Q4 2025, 3239000.0 in Q3 2025, and 5756000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -9.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.13 Mn |
| Jun 30, 2026 | -9.13 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | -5.76 Mn |
| Jun 30, 2025 | -5.76 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Mar 31, 2025 | -4.11 Mn |
| Dec 31, 2024 | -1.64 Mn |
| Dec 31, 2024 | -1.64 Mn |
| Sep 30, 2024 | -3.76 Mn |
| Sep 30, 2024 | -3.76 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -3.62 Mn |
| Mar 31, 2024 | -4.61 Mn |
| Mar 31, 2024 | -4.61 Mn |
| Dec 31, 2023 | -2.62 Mn |
| Dec 31, 2023 | -2.62 Mn |